J.W. Cole Advisors Inc. Lowers Stock Position in The Clorox Company $CLX

J.W. Cole Advisors Inc. lessened its position in shares of The Clorox Company (NYSE:CLXFree Report) by 53.3% during the 3rd quarter, Holdings Channel reports. The institutional investor owned 4,352 shares of the company’s stock after selling 4,976 shares during the period. J.W. Cole Advisors Inc.’s holdings in Clorox were worth $537,000 as of its most recent filing with the SEC.

A number of other large investors have also modified their holdings of the company. Total Investment Management Inc. acquired a new stake in shares of Clorox during the 2nd quarter valued at about $25,000. True Wealth Design LLC boosted its position in Clorox by 1,020.0% during the third quarter. True Wealth Design LLC now owns 224 shares of the company’s stock worth $28,000 after purchasing an additional 204 shares in the last quarter. NewSquare Capital LLC grew its holdings in Clorox by 567.6% in the second quarter. NewSquare Capital LLC now owns 227 shares of the company’s stock valued at $27,000 after purchasing an additional 193 shares during the period. Root Financial Partners LLC purchased a new stake in shares of Clorox in the third quarter valued at approximately $29,000. Finally, Bank & Trust Co acquired a new position in shares of Clorox during the 3rd quarter worth approximately $30,000. Institutional investors and hedge funds own 78.53% of the company’s stock.

Insider Buying and Selling

In related news, Director Pierre R. Breber purchased 4,000 shares of Clorox stock in a transaction dated Friday, November 21st. The shares were acquired at an average price of $104.13 per share, for a total transaction of $416,520.00. Following the acquisition, the director directly owned 13,000 shares in the company, valued at approximately $1,353,690. The trade was a 44.44% increase in their ownership of the stock. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Insiders own 0.63% of the company’s stock.

Analysts Set New Price Targets

CLX has been the subject of several recent analyst reports. JPMorgan Chase & Co. boosted their price target on shares of Clorox from $114.00 to $117.00 and gave the stock a “neutral” rating in a report on Wednesday, February 4th. Wells Fargo & Company boosted their target price on shares of Clorox from $108.00 to $115.00 and gave the stock an “equal weight” rating in a research note on Friday, January 23rd. BNP Paribas Exane reduced their price target on shares of Clorox from $103.00 to $101.00 and set an “underperform” rating for the company in a research report on Friday, January 16th. Rothschild & Co Redburn lowered their price objective on Clorox from $120.00 to $115.00 and set a “neutral” rating on the stock in a report on Wednesday, November 5th. Finally, Evercore cut their price objective on Clorox from $132.00 to $115.00 and set an “underperform” rating for the company in a research note on Wednesday, February 4th. One equities research analyst has rated the stock with a Buy rating, ten have assigned a Hold rating and five have given a Sell rating to the company. Based on data from MarketBeat.com, the stock has a consensus rating of “Reduce” and a consensus target price of $117.93.

View Our Latest Analysis on CLX

Clorox Price Performance

Clorox stock opened at $121.47 on Wednesday. The company has a fifty day simple moving average of $106.41 and a 200-day simple moving average of $113.58. The firm has a market capitalization of $14.69 billion, a price-to-earnings ratio of 19.85, a PEG ratio of 0.59 and a beta of 0.59. The company has a quick ratio of 0.48, a current ratio of 0.74 and a debt-to-equity ratio of 71.03. The Clorox Company has a 52-week low of $96.66 and a 52-week high of $159.04.

Clorox (NYSE:CLXGet Free Report) last posted its quarterly earnings results on Tuesday, February 3rd. The company reported $1.39 earnings per share for the quarter, missing analysts’ consensus estimates of $1.43 by ($0.04). Clorox had a return on equity of 383.01% and a net margin of 11.17%.The business had revenue of $1.67 billion for the quarter, compared to analyst estimates of $1.64 billion. During the same quarter in the previous year, the firm posted $1.55 earnings per share. The business’s revenue was down .8% compared to the same quarter last year. On average, equities analysts anticipate that The Clorox Company will post 7.15 EPS for the current fiscal year.

Clorox Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, February 13th. Investors of record on Wednesday, January 28th will be issued a $1.24 dividend. This represents a $4.96 annualized dividend and a dividend yield of 4.1%. The ex-dividend date of this dividend is Wednesday, January 28th. Clorox’s dividend payout ratio (DPR) is currently 81.05%.

About Clorox

(Free Report)

The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company’s flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.

Clorox’s diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.

See Also

Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Clorox Company (NYSE:CLXFree Report).

Institutional Ownership by Quarter for Clorox (NYSE:CLX)

Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.